<H1>Chapter DOI: 10.1007/s00105-014-3529-1<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>15</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>15</td></tr><tr><td>BibStructured Count</td><td width="10%">15</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>14</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381(9863):320&#8211;332</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(12)61140-4>10.1016/S0140-6736(12)61140-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T (1996) Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol 134(2):340&#8211;346</td><td><a href=http://dx.doi.org/10.1111/j.1365-2133.1996.tb07625.x>10.1111/j.1365-2133.1996.tb07625.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T (1996) A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106(6):1333&#8211;1338</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12349283>10.1111/1523-1747.ep12349283</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T (2009) Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 106(8):2800&#8211;2805</td><td><a href=http://dx.doi.org/10.1073/pnas.0809230106>10.1073/pnas.0809230106</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, Natsuaki Y, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T (2010) From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol 37(3):231&#8211;238</td><td><a href=http://dx.doi.org/10.1111/j.1346-8138.2009.00793.x>10.1111/j.1346-8138.2009.00793.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Schmidt E, Zillikens D (2009) Research in practice: diagnosis of subepidermal autoimmune bullous disorders. J Dtsch Dermatol Ges 7(4):296&#8211;300</td><td><a href=http://dx.doi.org/10.1111/j.1610-0387.2008.06974.x>10.1111/j.1610-0387.2008.06974.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, FirstPage, ArticleTitle, VolumeID, IssueID, Year</td><td>CrossRef</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Kasperkiewicz M, Zillikens D, Schmidt E (2012) Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 45(1):55&#8211;70</td><td><a href=http://dx.doi.org/10.3109/08916934.2011.606447>10.3109/08916934.2011.606447</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Goletz S, Hashimoto T, Zillikens D, Schmidt E (2014) Anti-p200 pemphigoid. J Am Acad Dermatol 71(1):185&#8211;191</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2014.02.036>10.1016/j.jaad.2014.02.036</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E (2010) Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clin Exp Dermatol 35(6):614&#8211;617</td><td><a href=http://dx.doi.org/10.1111/j.1365-2230.2009.03731.x>10.1111/j.1365-2230.2009.03731.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Shimanovich I, Petersen EE, Weyers W, Sitaru C, Zillikens D (2005) Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5. J Am Acad Dermatol 52:90&#8211;92</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2004.07.036>10.1016/j.jaad.2004.07.036</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Mitsuya J, Hara H, Ito K, Ishii N, Hashimoto T, Terui T (2008) Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol 158(6):1354&#8211;1357</td><td><a href=http://dx.doi.org/10.1111/j.1365-2133.2008.08483.x>10.1111/j.1365-2133.2008.08483.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Demitsu T, Yoneda K, Iida E, Sasaki K, Umemoto N, Kakurai M, Wakatabi K, Yamada T, Ohyama B, Hashimoto T (2009) A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 &nbsp;C-terminal domain, associated with pancreatic cancer. Clin Exp Dermatol 34(8):992&#8211;994</td><td><a href=http://dx.doi.org/10.1111/j.1365-2230.2009.03646.x>10.1111/j.1365-2230.2009.03646.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Kamata M, Fujita H, Hamanaka T, Takahashi K, Koga H, Hashimoto T, Sato S (2013) Anti-laminin &#947;1 pemphigoid accompanied by autoantibodies to laminin &#945;3 and &#947;2 subunits of laminin-332. JAMA Dermatol 149(12):1437&#8211;1439</td><td><a href=http://dx.doi.org/10.1001/jamadermatol.2013.5358>10.1001/jamadermatol.2013.5358</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Setterfield J, Shirlaw PJ, Kerr-Muir M, Neill S, Bhogal BS, Morgan P, Tilling K, Challacombe SJ, Black MM (1998) Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 138(4):602&#8211;610</td><td><a href=http://dx.doi.org/10.1046/j.1365-2133.1998.02168.x>10.1046/j.1365-2133.1998.02168.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E (2011) Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol 65(3):552&#8211;558</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2010.07.032>10.1016/j.jaad.2010.07.032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>